|
Global market for asthma treatment expected to reach $21.7 billion by 2020
News-Medical.net Despite generic erosion facing several of the leading asthma brands, such as Advair (fluticasone propionate/salmeterol xinafoate), Symbicort (budesonide/formoterol fumarate) and Xolair (omalizumab), the global market for asthma treatment is set to … |
View full post on asthma – Google News